Los Angeles Capital Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.96M | Sell |
|
|||||
|
2025
Q2 | $1.54M | Sell |
|
|||||
|
2025
Q1 | $1.88M | Buy |
|
|||||
|
2024
Q4 | $1.45M | Buy |
|
|||||
|
2024
Q3 | $1.21M | Buy |
|
|||||
|
2024
Q2 | $455K | Sell |
|
|||||
|
2024
Q1 | $893K | Buy |
|
|||||
|
2023
Q4 | $586K | Hold |
|
|||||
|
2023
Q3 | $437K | Buy |
|
|||||
|
2023
Q2 | $520K | Buy |
|
|||||
|
2023
Q1 | $514K | Sell |
|
|||||
|
2022
Q4 | $602K | Buy |
|
|||||
|
2022
Q3 | $333K | Buy |
|
|||||
|
2022
Q2 | $276K | Sell |
|
|||||
|
2022
Q1 | $752K | Hold |
|
|||||
|
2021
Q4 | $667K | Hold |
|
|||||
|
2021
Q3 | $913K | Sell |
|
|||||
|
2021
Q2 | $1.19M | Sell |
|
|||||
|
2021
Q1 | $983K | Sell |
|
|||||
|
2020
Q4 | $2.9M | Sell |
|
|||||
|
2020
Q3 | $2.26M | Buy |
|
|||||
|
2020
Q2 | $1.72M | Buy |
|
|||||
|
2020
Q1 | $851K | Buy |
|
|||||
|
2019
Q4 | $549K | Buy |
|
|||||
|
2019
Q3 | $329K | Hold |
|
|||||
|
2019
Q2 | $459K | Hold |
|
|||||
|
2019
Q1 | $452K | Hold |
|
|||||
|
2018
Q4 | $405K | Sell |
|
|||||
|
2018
Q3 | $625K | Buy |
|
|||||
|
2018
Q2 | $351K | Buy |
|
|||||
|
2014
Q2 | – | Sell |
|
|||||
|
2014
Q1 | $626K | Buy |
|